Christian Angermayer's Net Worth
$46.7 Million
Who is Christian Angermayer?
Christian Angermayer has an estimated net worth of $46.7 Million. This is based on reported shares across multiple companies, which include Alto Neuroscience, Inc., ATAI Life Sciences N.V., Sensei Biotherapeutics, Inc., and Frontier Acquisition Corp..
SEC CIK
Christian Angermayer's CIK is 0001845872
Past Insider Trading and Trends
2022 was Christian Angermayer's most active year for acquiring shares with 16 total transactions. Christian Angermayer's most active month to acquire stocks was the month of March. 2023 was Christian Angermayer's most active year for disposing of shares, totalling 2 transactions. Christian Angermayer's most active month to dispose stocks was the month of May. 2021 saw Christian Angermayer paying a total of $10,500,000.00 for 828,000 shares, this is the most they've acquired in one year. In 2023 Christian Angermayer cashed out on 3,441,661 shares for a total of $5,437,824.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alto Neuroscience, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 926.54K |
—
|
—
| 926.54K |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ATAI Life Sciences N.V. (ATAI) Snapshot price: $1.6725
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +3.93% | 1.21M |
$1.32 | $1,600,443.45 | 32.09M |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +9.22% | 136.39K |
$5.02 | $684,553.43 | 1.61M |
Apr 20 - Apr 21
| |||
Form 4
| +3.25% | 56.6K |
$4.46 | $252,490.15 | 1.8M |
Apr 28 - Apr 29
| |||
Form 4
| +3.94% | 66.01K |
$4.67 | $308,567.05 | 1.74M |
Apr 26 - Apr 27
| |||
Form 4
| +3.83% | 61.78K |
$4.82 | $297,804.68 | 1.68M |
Apr 22 - Apr 25
| |||
Form 4
| +8.80% | 119.64K |
$5.12 | $612,395.41 | 1.48M |
Apr 18 - Apr 19
| |||
Form 4
| +0.37% | 4.97K |
$5.19 | $25,778.73 | 1.36M |
Apr 14
| |||
Form 4
| +4.25% | 55.2K |
$4.88 | $269,560.07 | 1.35M |
Apr 12
| |||
Form 4
| +9.40% | 111.61K |
$4.82 | $538,194.10 | 1.3M |
Apr 8 - Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +3.59% | 700K |
$15.00 | $10,500,000.00 | 20.19M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sensei Biotherapeutics, Inc. (SNSE) Snapshot price: $0.761
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.44M |
$1.58 | -$5,437,824.38 |
0
|
Jun 1
| |||
Form 4
| +0.09% | 2.2K |
$1.61 | $3,539.03 | 2.49M |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Frontier Acquisition Corp. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||